Trials / Completed
CompletedNCT04345419
Remdesivir Efficacy in Coronavirus Disease
Remdesivir in COVID-19 Treatment: A Randomised Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
COVID 19 treatment using Remedesvir.
Detailed description
COVID 19 treatment using Remedesvir. Is this drug effective?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remdesivir | Remdesivir as antiviral drug |
| OTHER | Standard of care treatment | Standard of care treatment |
Timeline
- Start date
- 2020-06-16
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2020-04-14
- Last updated
- 2021-08-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04345419. Inclusion in this directory is not an endorsement.